Science Assets for Oncology Innovation - Lunch Roundtable at ICR

Developing new treatments, tools and systems to fight cancer increasingly depends on access to advanced scientific infrastructure, clinical expertise, patient datasets, specialist laboratory services, and translational research capabilities.
At the London Cancer Hub, in partnership with the Institute of Cancer Research (ICR), The Royal Marsden NHS Foundation Trust, Socius and Populate, we are opening access to a growing suite of scientific assets and innovation support services designed to help pioneering companies accelerate their R&D journeys.
We would be delighted to invite you to an industry roundtable and networking session to:
Tour the ICR’s core research facilities
Meet research scientists and technical specialists
Explore emerging infrastructure and service opportunities at the London Cancer Hub
Share insights on how these capabilities can best support innovative companies
We are particularly keen to hear your views on:
The equipment and infrastructure you need
How you would want to access and use these capabilities
Scientific and technical support requirements
Existing expertise gaps or partnership opportunities
Preferred commercial models, productisation and service packaging
The session will include refreshments, discussion with peers from across the innovation ecosystem, and an optional guided tour of the ICR’s core facilities.
We will host two sessions on Monday 15 June. Please join us for the one that is most convenient for you:
Lunch Roundtable: (this link)
12:00 – 14:00
Afternoon Tea Roundtable: https://luma.com/tgxjqljk
16:00 – 18:00
We are very keen to support companies in accessing and shaping the ecosystem being developed at the London Cancer Hub, and we would greatly value your perspective.
We look forward to meeting you and learning more about your innovation and R&D requirements.